2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa

Details for Australian Patent Application No. 2006291439 (hide)

Owner The Medicines Company (Leipzig) GmbH

Inventors Donnecke, Daniel; Sturzebecher, Anne; Schweinitz, Andrea; Sturzebecher, Jorg; Steinmetzer, Torsten

Agent Watermark

Pub. Number AU-B-2006291439

PCT Pub. Number WO2007/031343

Priority 10 2005 044 319.2 16.09.05 DE

Filing date 18 September 2006

Wipo publication date 22 March 2007

Acceptance publication date 13 September 2012

International Classifications

C07K 5/06 Peptides having up to four amino acids in a fully defined sequence

A61K 38/55 Medicinal preparations containing peptides - Protease inhibitors

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/031343 Priority application(s): WO2007/031343

28 May 2009 Alteration of Name

  The name of the applicant has been altered to The Medicines Company (Leipzig) GmbH

13 September 2012 Application Accepted

  Published as AU-B-2006291439

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006291445-Use of C3-C10 17alpha-esters of 9,11-dehydrocortexolone as antigonadotrophic agents.

2006291435-Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification